issues
search
opensafely
/
antibody-and-antiviral-deployment
While vaccines remain the best strategy to prevent COVID-19, mAbs could potentially benefit certain vulnerable populations before or after exposure to SARS-CoV-2, such as the unvaccinated or recently vaccinated high-risk patients.
MIT License
1
stars
4
forks
source link
feat: coverage by stp
#22
Closed
acagreen17
closed
2 years ago
gitpod-io[bot]
commented
2 years ago